Version 1.79 release notes

Release notes

Changes to the NVC have been made since the last release v1.78 (2025-09-25). For your reference, please find a summary of the changes below:

DIN

02445646 | FLUZONE HIGH-DOSE - SANOFI PASTEUR LIMITED | (Updated Health Canada product status)
02420686 | FLUVIRAL - ID BIOMEDICAL CORPORATION OF QUEBEC | (Updated Health Canada product status)
02552035 | COMIRNATY - BIONTECH MANUFACTURING GMBH | (Updated Health Canada product status)
02365936 | FLUZONE - SANOFI PASTEUR LIMITED | (Updated Health Canada product status)
02365707 | FLUZONE - SANOFI PASTEUR LIMITED | (Updated Health Canada product status)

Tradename

33361000087101 | [COVID-19] COMIRNATY (original strain) pediatric 10 mcg/0.2 mL | (Updated generic mapping)
271421000087109 | [Inf] FLUZONE Trivalent | (Updated generic, antigen, and market authorization holder mappings)